NeurAxis, a medical tech company, announced new insurance coverage for its PENFS therapy, IB-Stim, adding access for 26 million more people and bringing total coverage to over 147 million lives. IB-Stim is FDA-cleared to treat functional abdominal pain in patients aged 8 and older, addressing a significant unmet need especially in pediatric patients. The company is expanding its commercial team to capitalize on this growth and expects further coverage gains from major insurers, aiming for increased adoption and revenue growth.
NeurAxis's recent medical policy coverage milestone adds context to the health sector's market activity. For readers following health stocks, here is Pluang's market snapshot as of Oct 15, 2026 19:31 WIB: Among 150 priced health-sector US stocks, 95 rose and 46 fell today. Takeda Pharmaceutical (TAK) rose 2.58% to USD 19.50 with a typical hold time of 6 days, DexCom (DXCM) gained 2.52% to USD 85.57 with 100% buy orders and a typical hold time of 62 days, while Tilray Brands (TLRY) declined 2.55% to USD 3.06 despite 84% buy orders and a longer typical hold time of 31 days.
Alignment Health Plan will expand its Medicare Advantage coverage to Bexar and Comal counties in San Antonio starting January 1, 2027, providing access to coordinated care and trusted local providers for over 392,000 Medicare beneficiaries. This expa...
Interactive Brokers is set to report Q3 2026 earnings of $0.67 per share and revenue of $1.86 billion, reflecting year-over-year growth of about 16% in earnings and 13.5% in revenue. Growth is driven by increased trading activity, more client account...
CareCloud, a leader in AI-powered healthcare technology and revenue cycle management, will announce its financial results for Q3 2026 on November 5 before the market opens. The company will host a conference call at 8:30 a.m. ET to discuss the result...
Morgan Stanley analyst Joseph Moore lowered IonQ's price target from $49 to $43 following the company's announcement of a $2 billion financing deal with Heights Capital Management. The deal involves issuing 20.5 million new shares and 29.5 million pr...
Investec Bank plc, acting as joint broker for Gamma Communications Plc, disclosed its share transactions on October 14, 2026. The bank purchased 195,636 ordinary shares at prices between 1093 and 1093.1, and sold 188,669 shares at prices ranging from...
